Related Experiment Videos
Stent grafts for aortic aneurysms: the next interventional challenge
B T Katzen1, G J Becker, J F Benenati
1Miami Cardiac and Vascular Institute, Florida 33176, USA.
The American Journal of Cardiology
|April 29, 1998
Summary
Endovascular stent grafts offer a less invasive approach for treating aneurysms and occlusive vascular disease, potentially reducing hospital stays and improving outcomes. Further research is needed for newer device generations.
Area of Science:
- Vascular Surgery
- Medical Devices
- Endovascular Interventions
Background:
- Stent grafts (endografts) are utilized for endoluminal exclusion of peripheral and aortic aneurysms.
- Their application extends to occlusive vascular disease and post-surgical complications.
- Ongoing clinical trials evaluate diverse endograft designs, including unsupported and supported (endo/exoskeleton) types.
Purpose of the Study:
- To review the current applications and emerging technologies of endovascular grafts.
- To highlight the procedural requirements and potential benefits of endovascular grafting.
- To identify areas for improvement in next-generation endograft devices.
Main Methods:
- Review of current clinical trials and device evaluations for endovascular grafts.
- Discussion of endograft delivery systems, including percutaneous approaches.
- Emphasis on the critical role of advanced imaging (CT, angiography) for pretreatment planning.
Main Results:
- Endovascular grafts can be delivered via minimally invasive techniques, including small arteriotomies and percutaneous access.
- Unsupported grafts demonstrate efficacy despite potential challenges like kinking.
- Modular designs allow for complex reconstructions and extensions.
Conclusions:
- Endovascular grafting offers potential advantages such as reduced hospital stay, less invasive procedures, and lower morbidity/mortality.
- Sophisticated imaging and planning are crucial for successful endovascular graft procedures.
- Further development is required to address unresolved issues in newer endograft generations.